Matinas BioPharma Inc. (MTNB) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Matinas BioPharma Inc.

    AMEX: MTNB · Real-Time Price · USD
    1.95
    0.01 (0.52%)
    At close: Oct 06, 2025, 1:25 PM

    Matinas BioPharma Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -24.25M -22.94M -21M -23.28M
    Depreciation & Amortization
    		 972K 941K 898K 781.49K
    Stock-Based Compensation
    		 3.19M 4.95M 5.23M 4.29M
    Other Working Capital
    		 288K 1.77M -4.47M 945.13K
    Other Non-Cash Items
    		 4.41M 108K 504K 1.45M
    Deferred Income Tax
    		 -84K n/a n/a 2.21K
    Change in Working Capital
    		 -131K 1.67M -4.79M 1.53M
    Operating Cash Flow
    		 -15.88M -15.28M -19.16M -15.22M
    Capital Expenditures
    		 n/a -218K -892K -260.38K
    Cash Acquisitions
    		 n/a n/a -5.77M -17.03M
    Purchase of Investments
    		 -8.44M n/a -9.48M -23.19M
    Sales Maturities Of Investments
    		 17.64M 13.46M 15.25M 40.23M
    Other Investing Acitivies
    		 n/a n/a 5.77M 17.03M
    Investing Cash Flow
    		 9.21M 13.24M 4.88M 16.77M
    Debt Repayment
    		 -5K -7K -20K -30K
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a -843.6M
    Other Financial Acitivies
    		 n/a n/a 99K 845.01M
    Financial Cash Flow
    		 9.17M -7K 79K 6.96M
    Net Cash Flow
    		 2.5M -2.04M -14.2M 8.51M
    Free Cash Flow
    		 -15.88M -15.5M -20.05M -15.48M

    Add to Watchlist